Literature DB >> 10733905

High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils.

O F Olesen1, L Dagø.   

Abstract

The extracellular deposition of amyloid beta (Abeta) in senile plaques constitutes one of the defining hallmarks of Alzheimer's disease. Abeta peptides can aggregate spontaneously to highly insoluble amyloid fibrils, but several components are likely to influence the kinetics of fibrillogenesis in vivo. We report here that high density lipoprotein (HDL), the predominant lipoprotein in the human brain, reduces amyloid formation in vitro as determined by thioflavin T fluorescence and high speed sedimentation assays. The inhibition occurred in a dose dependent manner, and with concentrations of HDL above 1% resulting in more than 70% inhibition. We also examined the combined effect of apolipoprotein E (apoE) and HDL on Abeta fibrillogenesis. We found that HDL particles enriched with any of the three apoE isoforms inhibited Abeta fibrillogenesis as their native counterparts. Taken together, these findings suggest that HDL-like particles in the brain may prevent the formation of Abeta fibrils. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733905     DOI: 10.1006/bbrc.2000.2372

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-30       Impact factor: 8.311

2.  Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

Authors:  E Rodríguez; I Mateo; J Infante; J Llorca; J Berciano; O Combarros
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state.

Authors:  M M Pallitto; R M Murphy
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

4.  CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.

Authors:  Elizabeth A Murphy; John Cooper Roddey; Linda K McEvoy; Dominic Holland; D J Hagler; Anders M Dale; James B Brewer
Journal:  Brain Imaging Behav       Date:  2012-03       Impact factor: 3.978

5.  Effect of age stratification on the association between carotid intima-media thickness and cognitive impairment in Chinese hypertensive patients: new insight from the secondary analysis of the China Stroke Primary Prevention Trial (CSPPT).

Authors:  Junpei Li; Ling Guo; Lishun Liu; Chengzhang Liu; Lijing Ye; Yun Song; Genfu Tang; Binyan Wang; Xianhui Qin; Yan Zhang; Jianping Li; Ping Li; Huihui Bao; Yanqing Wu; Xiping Xu; Xiaobin Wang; Yong Huo; Xiao Huang; Xiaoshu Cheng
Journal:  Hypertens Res       Date:  2021-09-07       Impact factor: 3.872

6.  Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.

Authors:  Simona Vuletic; Ge Li; Elaine R Peskind; Hal Kennedy; Santica M Marcovina; James B Leverenz; Eric C Petrie; Virginia M-Y Lee; Douglas Galasko; Gerard D Schellenberg; John J Albers
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

7.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

8.  Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier.

Authors:  Anil Paul Chirackal Manavalan; Alexandra Kober; Jari Metso; Ingrid Lang; Tatjana Becker; Karin Hasslitzer; Martina Zandl; Elham Fanaee-Danesh; Jyotsna Brijesh Pippal; Vinay Sachdev; Dagmar Kratky; Jasminka Stefulj; Matti Jauhiainen; Ute Panzenboeck
Journal:  J Biol Chem       Date:  2013-12-25       Impact factor: 5.157

9.  Use of copper and insulin-resistance to accelerate cognitive deficits and synaptic protein loss in a rat Abeta-infusion Alzheimer's disease model.

Authors:  Aynun N Begum; Fusheng Yang; Edmond Teng; Shuxin Hu; Mychica R Jones; Emily R Rosario; Walter Beech; Beverly Hudspeth; Oliver J Ubeda; Greg M Cole; Sally A Frautschy
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

10.  Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults.

Authors:  Erin Elizabeth Sundermann; Cuiling Wang; Mindy Katz; Molly E Zimmerman; Carol A Derby; Charles B Hall; Laurie J Ozelius; Richard B Lipton
Journal:  Neurobiol Aging       Date:  2016-02-16       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.